Strategy - Pharmaceutical Executive

Strategy

The art and science of running a successful pharmaceutical company.

Sales Force Survey: Still Too Much Business as Usual?

February 1, 2012
By:Ian Wilcox, Carrie Fisher, Matt Gurin

In the global battle for market share, the ability to adapt and mobilize your human assets around a responsive commercial model is a key variable of success.

Best to Market

February 1, 2012
By:Ben Comer

Pharm Exec's Brand of the Year: Abbott's Humira

Prizing the Eye : Brent Saunders, CEO Bausch + Lomb

February 1, 2012
By:Ben Comer

Bausch + Lomb CEO Brent Saunders refocuses on the customer.

iPad Apps: Are You Content with your Content?

January 1, 2012
By:Julian Upton, European Editor, Pharmaceutical Executive

Pharma has become unusually quick to strike embrace the iPad. But the industry's inherent conservatism means it has some way to go to fully milk the device's potential.

Copay Cards and Coupons: Letting the Facts Get in the Way

January 1, 2012
By:Mason Tenaglia

Mason Tenaglia offers empirical defense of coupons and copay offset programs.

Pharma 2012: Hard Times Before the Harvest

January 1, 2012
By: William Looney

The challenge for 2012 is that many new treatments may not complete the move from 'bench to bedside' in time to plug the yawning revenue gap.

Compliance: Getting Those Ducks in a Row

January 1, 2012
By:Jennifer Ringler

Pharma must coordinate the efforts of medical, legal, HR, global partners and many other players in the regulatory compliance space to keep itself afloat in choppy seas.